Al's Comment:

 Very impressive results, with no major side effects.   We need the FDA to approve treatments like this even though there is a small number of patients and it was not a randomized trial.


Posted on: 12/16/2022

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

 


Click HERE to return to brain tumor news headlines.


Our Terms of Use and Privacy Policy has changed.
Click HERE to read it!